Trials / Completed
CompletedNCT03627117
Influence of CBD on Episodic Memory in Healthy Subjects
Randomized Placebo Controlled Cross-over Study Investigating the Influence of CBD on Episodic Memory in Healthy Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Prof. Dominique de Quervain, MD · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
Placebo controlled, randomized, double blind, cross-over design. Single vape of 0.25ml 5% CBD e-liquid (12.5mg CBD) and single vape of 0.25ml e-liquid, tastes like lemon and madeleine. 15min vape time each. A total of 34 participants, equal number of male and female. There will be replacement of Drop-Outs until data from 34 participants are completed. The primary endpoint will be performance in a verbal memory task. The secondary endpoint will be performance in a working memory test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Verum | Single vape of 0.25mL of CBD e-Liquid containing: 5% CBD (low-temperature extracted Cannabidiol from Cannabis sativa L., purity 99%), Glycerine (vegetable), Propylene glycol, water |
| DRUG | Placebo | Single vape of 0.25ml e-liquid La Baronne Jaune, BORDO2. |
Timeline
- Start date
- 2018-08-13
- Primary completion
- 2018-12-08
- Completion
- 2018-12-08
- First posted
- 2018-08-13
- Last updated
- 2020-09-25
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03627117. Inclusion in this directory is not an endorsement.